Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations
Audra Schwalk, David E. Ost, Sahara N. Saltijeral, Henriette De La Garza, Roberto F. Casal, Carlos A. Jimenez, Georgie A. Eapen, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jack Lee, Yasir Y. Elamin, Jianjun Zhang, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Horiana B. Grosu
Topics & Concepts
MedicineThoracentesisPleural effusionMalignant pleural effusionInternal medicineOncologyHazard ratioRetrospective cohort studyLung cancerProportional hazards modelCohortUnivariate analysisSurgeryRadiologyMultivariate analysisConfidence intervalPleural and Pulmonary DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Treatments and Mutations